Analyst Ryan MacDonald from Needham maintained a Buy rating on Phreesia (PHR – Research Report) and keeping the price target at $29.00.Stay ...

Citi raised the firm’s price target on Phreesia (PHR) to $35 from $31 and keeps a Buy rating on the shares as part of a 2025 outcook for the ...

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 92.1% of Phreesia shares are owned by institutional investors. 6.1% of OptimizeRx shares are owned by insiders.

Navy data scientists built the tool to help Adm. Franchetti and her staff track top-priority topics with a few clicks.

Android Auto version 13.4 is rolling out a refreshed look for its media player UI, with a new font, and rearranged buttons.

Healthcare software as a service (SaaS) company Phreesia is notifying over 910,000 people that their personal and health data was exposed in a May breach of its subsidiary ConnectOnCall ...

Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. The company had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million.

Phreesia (PHR) closed the last trading session at $23.84, gaining 25.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

Modern cars often come equipped with features whose functions we might not understand, such as the plastic spherical detail ...